CG Oncology, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| – | +151.7% | +34.9% | +278.7% | +4.9% | |
| – | +152.0% | +31.9% | +288.5% | +0.7% | |
| – | +64.4% | -90.6% | +3,009.9% | -87.4% | |
| – | +167.7% | +30.8% | +295.4% | +0.0% | |
| – | +15,050.0% | -69.6% | +748.9% | -11.9% | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | – | – | – | – | |
| – | +22.4% | -35.7% | +47.6% | +82.0% | |
| – | +158.2% | -7.6% | +49.9% | +44.3% | |
| – | +203.6% | -91.4% | -76.3% | +391.9% | |
| – | -1.8% | +229.1% | +101.0% | -12.3% | |
| – | -45.9% | – | – | – | |
| – | +211.0% | +47.6% | +296.9% | +2.6% | |
| – | – | – | – | – | |
| – | +0.0% | +0.0% | -6.2% | +23.7% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.